Zenas BioPharma's immune disorder drug meets main goal in late-stage trial
Zenas BioPharma, Inc.Zenas BioPharma, Inc.(US:ZBIO) Reuters·2026-01-05 21:29

公司研发进展 - Zenas BioPharma 宣布其试验性药物在一项针对罕见免疫系统相关疾病的后期研究中降低了疾病发作风险 该疾病会随时间推移损害器官 [1]

Zenas BioPharma, Inc.-Zenas BioPharma's immune disorder drug meets main goal in late-stage trial - Reportify